Details
Stereochemistry | ABSOLUTE |
Molecular Formula | 2C22H24N2O8.C2H6O.2ClH.H2O |
Molecular Weight | 1025.875 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 12 / 12 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
O.Cl.Cl.CCO.[H][C@@]12[C@@H](C)C3=CC=CC(O)=C3C(=O)C1=C(O)[C@]4(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@]4([H])[C@H]2O.[H][C@@]56[C@@H](C)C7=CC=CC(O)=C7C(=O)C5=C(O)[C@]8(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@]8([H])[C@H]6O
InChI
InChIKey=HALQELOKLVRWRI-VDBOFHIQSA-N
InChI=1S/2C22H24N2O8.C2H6O.2ClH.H2O/c2*1-7-8-5-4-6-9(25)11(8)16(26)12-10(7)17(27)14-15(24(2)3)18(28)13(21(23)31)20(30)22(14,32)19(12)29;1-2-3;;;/h2*4-7,10,14-15,17,25,27-29,32H,1-3H3,(H2,23,31);3H,2H2,1H3;2*1H;1H2/t2*7-,10+,14+,15-,17-,22-;;;;/m00..../s1
Molecular Formula | C22H24N2O8 |
Molecular Weight | 444.4346 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 5 / 6 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Molecular Formula | C2H6O |
Molecular Weight | 46.0684 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | H2O |
Molecular Weight | 18.0153 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | ClH |
Molecular Weight | 36.461 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:19:34 UTC 2023
by
admin
on
Fri Dec 15 15:19:34 UTC 2023
|
Record UNII |
19XTS3T51U
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C1595
Created by
admin on Fri Dec 15 15:19:34 UTC 2023 , Edited by admin on Fri Dec 15 15:19:34 UTC 2023
|
||
|
CFR |
21 CFR 522.778
Created by
admin on Fri Dec 15 15:19:34 UTC 2023 , Edited by admin on Fri Dec 15 15:19:34 UTC 2023
|
||
|
EU-Orphan Drug |
EU/3/12/955
Created by
admin on Fri Dec 15 15:19:34 UTC 2023 , Edited by admin on Fri Dec 15 15:19:34 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
23663
Created by
admin on Fri Dec 15 15:19:34 UTC 2023 , Edited by admin on Fri Dec 15 15:19:34 UTC 2023
|
PRIMARY | RxNorm | ||
|
m4758
Created by
admin on Fri Dec 15 15:19:34 UTC 2023 , Edited by admin on Fri Dec 15 15:19:34 UTC 2023
|
PRIMARY | Merck Index | ||
|
SUB01830MIG
Created by
admin on Fri Dec 15 15:19:34 UTC 2023 , Edited by admin on Fri Dec 15 15:19:34 UTC 2023
|
PRIMARY | |||
|
C29007
Created by
admin on Fri Dec 15 15:19:34 UTC 2023 , Edited by admin on Fri Dec 15 15:19:34 UTC 2023
|
PRIMARY | |||
|
100000092638
Created by
admin on Fri Dec 15 15:19:34 UTC 2023 , Edited by admin on Fri Dec 15 15:19:34 UTC 2023
|
PRIMARY | |||
|
19XTS3T51U
Created by
admin on Fri Dec 15 15:19:34 UTC 2023 , Edited by admin on Fri Dec 15 15:19:34 UTC 2023
|
PRIMARY | |||
|
50845
Created by
admin on Fri Dec 15 15:19:34 UTC 2023 , Edited by admin on Fri Dec 15 15:19:34 UTC 2023
|
PRIMARY | |||
|
34730
Created by
admin on Fri Dec 15 15:19:34 UTC 2023 , Edited by admin on Fri Dec 15 15:19:34 UTC 2023
|
PRIMARY | |||
|
19XTS3T51U
Created by
admin on Fri Dec 15 15:19:34 UTC 2023 , Edited by admin on Fri Dec 15 15:19:34 UTC 2023
|
PRIMARY | |||
|
741421
Created by
admin on Fri Dec 15 15:19:34 UTC 2023 , Edited by admin on Fri Dec 15 15:19:34 UTC 2023
|
PRIMARY | |||
|
DTXSID4041020
Created by
admin on Fri Dec 15 15:19:34 UTC 2023 , Edited by admin on Fri Dec 15 15:19:34 UTC 2023
|
PRIMARY | |||
|
1226003
Created by
admin on Fri Dec 15 15:19:34 UTC 2023 , Edited by admin on Fri Dec 15 15:19:34 UTC 2023
|
PRIMARY | |||
|
DBSALT000896
Created by
admin on Fri Dec 15 15:19:34 UTC 2023 , Edited by admin on Fri Dec 15 15:19:34 UTC 2023
|
PRIMARY | |||
|
24390-14-5
Created by
admin on Fri Dec 15 15:19:34 UTC 2023 , Edited by admin on Fri Dec 15 15:19:34 UTC 2023
|
PRIMARY | |||
|
CHEMBL1433
Created by
admin on Fri Dec 15 15:19:34 UTC 2023 , Edited by admin on Fri Dec 15 15:19:34 UTC 2023
|
PRIMARY | |||
|
DOXYCYCLINE HYCLATE
Created by
admin on Fri Dec 15 15:19:34 UTC 2023 , Edited by admin on Fri Dec 15 15:19:34 UTC 2023
|
PRIMARY | Description: A yellow, crystalline powder.Solubility: Soluble in 3 parts of water and in 4 parts of methanol R; practically insoluble in ether R.Category: Antibacterial and antimalarial drug.Storage: Doxycycline hyclate should be kept in a tightly closed container, protected from light.Additional information: Even in the absence of light, Doxycycline hyclate is gradually degraded on exposure to a humid atmosphere, the decomposition being faster at higher temperatures.Requirements: Definition. Doxycycline hyclate contains not less than 95% and not more than 102% of C22H24N2O8,HCl, calculated with reference to the anhydrous and ethanol-free substance. |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE | |||
|
ANHYDROUS->SOLVATE | |||
|
BASIS OF STRENGTH->SUBSTANCE |
ASSAY (HPLC)
USP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT | |||
|
IMPURITY -> PARENT | |||
|
IMPURITY -> PARENT | |||
|
IMPURITY -> PARENT | |||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT | |||
|
IMPURITY -> PARENT | |||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Biological Half-life | PHARMACOKINETIC |
|
|
|||
Tmax | PHARMACOKINETIC |
|
SUBGINGIVAL, CONTROLLED-RELEASE: 2 HOURS |
|
||